Updates in the Treatment of HR+ Breast Cancer - Episode 5

Potential With Individual Tumor Sequencing With Bespoke Testing Methodologies and ctDNA

, , ,

A panel of experts discuss the potential of individual tumor sequencing with bespoke testing methodologies.

Video content above is prompted by the following:

  • What are the available first- or second-line treatment options for HR+ advanced/metastatic breast cancer? (CDK4/6i +/- ET, etc.)